Mack Anthony P. 4
4 · Virpax Pharmaceuticals, Inc. · Filed Nov 22, 2021
Insider Transaction Report
Form 4
Mack Anthony P.
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock, $0.00001 par value
2021-11-18$3.99/sh+25,125$100,249→ 176,812 total
Holdings
- 2,730,438(indirect: By LLC)
Common Stock, $0.00001 par value
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at prices ranging from $3.935 to $4.10 per share, inclusive. The Reporting Person undertakes to provide to Virpax Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F2]The Reporting Person owns 88.8888% of the outstanding member units of Virpax Pharmaceuticals, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.